Allianz Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Sell |
|
|||||
|
2025
Q1 | $2.58M | Sell |
|
|||||
|
2024
Q4 | $5.65M | Buy |
|
|||||
|
2024
Q3 | $5.43M | Sell |
|
|||||
|
2024
Q2 | $7.18M | Buy |
|
|||||
|
2024
Q1 | $5.4M | Buy |
|
|||||
|
2023
Q4 | $2.62M | Buy |
|
|||||
|
2023
Q3 | $3.2M | Buy |
|
|||||
|
2023
Q2 | $2.66M | Buy |
|
|||||
|
2023
Q1 | $1.07M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $451K | Hold |
|
|||||
|
2022
Q1 | $470K | Hold |
|
|||||
|
2021
Q4 | $542K | Hold |
|
|||||
|
2021
Q3 | $556K | Sell |
|
|||||
|
2021
Q2 | $585K | Sell |
|
|||||
|
2021
Q1 | $615K | Sell |
|
|||||
|
2020
Q4 | $4.84M | Buy |
|
|||||
|
2020
Q3 | $3.17M | Sell |
|
|||||
|
2020
Q2 | $4.93M | Buy |
|
|||||
|
2020
Q1 | $2.89M | Sell |
|
|||||
|
2019
Q4 | $6.76M | Sell |
|
|||||
|
2019
Q3 | $4.18M | Sell |
|
|||||
|
2019
Q2 | $39M | Buy |
|
|||||
|
2019
Q1 | $30.2M | Buy |
|
|||||
|
2018
Q4 | $16.1M | Buy |
|
|||||
|
2018
Q3 | $13.8M | Buy |
|
|||||
|
2018
Q2 | $8.67M | Sell |
|
|||||
|
2018
Q1 | $5.47M | Buy |
|
|||||
|
2017
Q4 | $3.62M | Sell |
|
|||||
|
2017
Q3 | $3.25M | Sell |
|
|||||
|
2017
Q2 | $2.41M | Buy |
|
|||||
|
2017
Q1 | $1.89M | Buy |
|
|||||
|
2016
Q4 | $1.68M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.55M | Sell |
|
|||||
|
2015
Q4 | $10.2M | Buy |
|
|||||
|
2015
Q3 | $5.98M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $298K | Hold |
|
|||||
|
2014
Q1 | $240K | Sell |
|
|||||
|
2013
Q4 | $469K | Sell |
|
|||||
|
2013
Q3 | $1.2M | Sell |
|
|||||
|
2013
Q2 | $2.96M | Buy |
|